Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | |
---|---|---|
Operating Cash Flow (Indirect Method) | ||
Cash flow from continuing operating activities | 1,046.09%540.33K | -57.11K |
Net income from continuing operations | 200.97%1.06M | --351.07K |
Operating gains losses | -311.82%-9.32K | --4.4K |
Depreciation and amortization | -7.17%40.72K | --43.86K |
Deferred tax | -240.36%-47.24K | --33.65K |
Change In working capital | -17.83%-505.52K | ---429.01K |
-Change in receivables | -1,382.40%-1.61M | ---108.86K |
-Change in prepaid assets | 200.00%1.28K | ---1.28K |
-Change in payables and accrued expense | 449.99%1.15M | ---329.56K |
-Change in other current liabilities | 51.01%-11.8K | ---24.08K |
-Change in other working capital | -200.00%-34.77K | --34.77K |
Cash from discontinued investing activities | ||
Operating cash flow | 1,046.09%540.33K | ---57.11K |
Investing cash flow | ||
Cash flow from continuing investing activities | 128.35%6.41K | -22.61K |
Net PPE purchase and sale | 128.35%6.41K | ---22.61K |
Cash from discontinued investing activities | ||
Investing cash flow | 128.35%6.41K | ---22.61K |
Financing cash flow | ||
Cash flow from continuing financing activities | -292.25%-33.91K | -8.65K |
Net issuance payments of debt | -292.25%-33.91K | ---8.65K |
Cash from discontinued financing activities | ||
Financing cash flow | -292.25%-33.91K | ---8.65K |
Net cash flow | ||
Beginning cash position | -18.96%377.75K | --466.11K |
Current changes in cash | 680.36%512.83K | ---88.36K |
End cash Position | 135.76%890.58K | --377.75K |
Free cash flow | 777.80%540.33K | ---79.72K |
Currency Unit | USD | USD |